Prostate Cancer - Results from #60

Age-related activity of Poly (ADP-ribose) polymerase (PARP) in men with localized prostate cancer. April 23, 2021

Effects of once-yearly zoledronic acid on bone density and incident vertebral fractures in nonmetastatic castration-sensitive prostate cancer patients with osteoporosis. April 23, 2021

ZERO — The End of Prostate Cancer and Us TOO International to Merge to Better Serve the Prostate Cancer Community April 22, 2021

UpFrontPSMA: A Randomized Phase 2 Study of Sequential 177Lu‐PSMA‐617 and Docetaxel vs Docetaxel in Metastatic Hormone‐naïve Prostate Cancer (Clinical Trial Protocol) April 22, 2021

Standardisation of prostate multiparametric MRI across a hospital network: a London experience. April 22, 2021

The Development of iManage-PC, an Online Symptom Monitoring and Self-management Tool for Men With Clinically Localized Prostate Cancer. April 22, 2021

Prostate cancer outcomes disparities: Population survival analysis in an ethnically diverse nation. April 22, 2021

Potential Candidates for Focal Therapy in Prostate Cancer in the Era of Magnetic Resonance Imaging-targeted Biopsy: A Large Multicenter Cohort Study. April 22, 2021

Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era? April 22, 2021

Family history in patients who would have been candidates for active surveillance. April 21, 2021

Musculoskeletal Responses to Exercise plus Nutrition in Men with Prostate Cancer on Androgen Deprivation: A 12-month RCT. April 21, 2021

Limited versus Extended Pelvic Lymph Node Dissection for Prostate Cancer: A Randomized Clinical Trial. April 21, 2021

Cardiovascular Events in Men with Prostate Cancer Receiving Hormone Therapy: An Analysis of the FDA Adverse Event Reporting System (FAERS). April 21, 2021

New Urine-Based, Multi-Biomarker Test Holds Promise for Detecting Aggressive Prostate Cancer April 20, 2021

NF-κB blockade with oral administration of dimethylaminoparthenolide, delays prostate cancer resistance to androgen receptor inhibition and inhibits AR variants. April 20, 2021

Consensus on Treatment and Follow-Up for Biochemical Recurrence in Castration-Sensitive Prostate Cancer: A Report From the First Global Prostate Cancer Consensus Conference for Developing Countries. April 20, 2021

Consensus on Screening, Diagnosis, and Staging Tools for Prostate Cancer in Developing Countries: A Report From the First Prostate Cancer Consensus Conference for Developing Countries (PCCCDC). April 20, 2021

Exploratory assessment of pineal gland volume, composition, and urinary 6-sulfatoxymelatonin levels on prostate cancer risk. April 20, 2021

Intra-patient comparison of physiologic 68Ga-PSMA-11 and 18F-DCFPyL PET/CT uptake in ganglia in prostate cancer patients: a pictorial essay. April 20, 2021

Consensus on Prostate Cancer Treatment of Localized Disease With Very Low, Low, and Intermediate Risk: A Report From the First Prostate Cancer Consensus Conference for Developing Countries (PCCCDC). April 20, 2021

Page 4 of 1149